ArticleCancer science2015

Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

Atsushi Kurabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.